These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 29242243)

  • 1. An Infrared Dye-Conjugated Virus-like Particle for the Treatment of Primary Uveal Melanoma.
    Kines RC; Varsavsky I; Choudhary S; Bhattacharya D; Spring S; McLaughlin R; Kang SJ; Grossniklaus HE; Vavvas D; Monks S; MacDougall JR; de Los Pinos E; Schiller JT
    Mol Cancer Ther; 2018 Feb; 17(2):565-574. PubMed ID: 29242243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage polarization contributes to the efficacy of an oncolytic HSV-1 targeting human uveal melanoma in a murine xenograft model.
    Liu S; Zhang J; Fang S; Zhang Q; Zhu G; Tian Y; Zhao M; Liu F
    Exp Eye Res; 2021 Jan; 202():108285. PubMed ID: 33039456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes Simplex Virus 1 Infection Promotes the Growth of a Subpopulation of Tumor Cells in Three-Dimensional Uveal Melanoma Cultures.
    Valyi-Nagy T; Fredericks B; Ravindra A; Hopkins J; Shukla D; Valyi-Nagy K
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor efficacy of oncolytic HSV-1 expressing cytosine deaminase is synergistically enhanced by DPD down-regulation and EMT inhibition in uveal melanoma xenograft.
    Liu S; Zhang J; Fang S; Su X; Zhang Q; Zhu G; Zhu L; Zhao M; Liu F
    Cancer Lett; 2020 Dec; 495():123-134. PubMed ID: 32946963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.
    Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R
    Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenovirus-based strategies enhance antitumor capability through p53-mediated downregulation of MGMT in uveal melanoma.
    Li X; Yuan L; Zhao J; Yang H; Yang Y; Zhang Y; Cun B
    Cancer Biol Ther; 2017 Mar; 18(3):194-199. PubMed ID: 28278076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans.
    Bramante S; Kaufmann JK; Veckman V; Liikanen I; Nettelbeck DM; Hemminki O; Vassilev L; Cerullo V; Oksanen M; Heiskanen R; Joensuu T; Kanerva A; Pesonen S; Matikainen S; Vähä-Koskela M; Koski A; Hemminki A
    Int J Cancer; 2015 Oct; 137(7):1775-83. PubMed ID: 25821063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncolytic virus H101 combined with GNAQ siRNA-mediated knockdown reduces uveal melanoma cell viability.
    Li Y; He J; Qiu C; Shang Q; Qian G; Fan X; Ge S; Jia R
    J Cell Biochem; 2019 Apr; 120(4):5766-5776. PubMed ID: 30320917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of tumor invasiveness, the extracellular matrix, and chromatin sequestration in the susceptibility of uveal melanoma to herpes simplex virus type 1.
    Valyi-Nagy K; Folberg R; Valyi-Nagy T; Maniotis AJ
    Exp Eye Res; 2007 May; 84(5):991-1000. PubMed ID: 17386925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of virus resistant tumor cell subpopulations in three-dimensional uveal melanoma cultures.
    Valyi-Nagy K; Dosa S; Kovacs SK; Bacsa S; Voros A; Shukla D; Folberg R; Valyi-Nagy T
    Cancer Gene Ther; 2010 Apr; 17(4):223-34. PubMed ID: 19893596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of oncolytic adenovirus and dacarbazine attenuates antitumor ability against uveal melanoma cells via cell cycle block.
    Cun B; Song X; Jia R; Zhao X; Wang H; Ge S; Fan X
    Cancer Biol Ther; 2012 Jan; 13(2):77-84. PubMed ID: 22336909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oncolytic ECHO-7 virus strain Rigvir on uveal melanoma cell lines.
    Tilgase A; Grīne L; Blāķe I; Borodušķis M; Rasa A; Alberts P
    BMC Res Notes; 2020 Apr; 13(1):222. PubMed ID: 32299493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant oncolytic adenovirus H101 combined with siBCL2: cytotoxic effect on uveal melanoma cell lines.
    Huang X; Jia R; Zhao X; Liu B; Wang H; Wang J; Zhou Y; Cun B; Ge S; Fan X
    Br J Ophthalmol; 2012 Oct; 96(10):1331-8. PubMed ID: 22843987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
    Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
    J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PHA665752 inhibits the HGF-stimulated migration and invasion of cells by blocking PI3K/AKT pathway in uveal melanoma.
    Wang Z; He C; Liu L; Ma N; Chen X; Zheng D; Qiu GH
    Neoplasma; 2017; 64(3):377-388. PubMed ID: 28253717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD71-Specific Aptamer Conjugated with Monomethyl Auristatin E for the Treatment of Uveal Melanoma.
    Zhang H; Jin C; Zhang L; Peng B; Zhang Y; Liu Y; Li L; Ye M; Xiong W; Tan W
    ACS Appl Mater Interfaces; 2022 Jan; 14(1):32-40. PubMed ID: 34928139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.
    Surriga O; Rajasekhar VK; Ambrosini G; Dogan Y; Huang R; Schwartz GK
    Mol Cancer Ther; 2013 Dec; 12(12):2817-26. PubMed ID: 24140933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-inducible HtrA2 gene enhances radiosensitivity of uveal melanoma OCM-1 cells in vitro and in vivo.
    Zhang F; Yu T; Yi CL; Sun XF
    Clin Exp Ophthalmol; 2014 Nov; 42(8):761-8. PubMed ID: 24606398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
    Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo studies of ocular topically administered NLC for the treatment of uveal melanoma.
    Cimino C; Sánchez López E; Bonaccorso A; Bonilla L; Musumeci T; Badia J; Baldomà L; Pignatello R; Marrazzo A; Barbaraci C; García ML; Carbone C
    Int J Pharm; 2024 Jul; 660():124300. PubMed ID: 38851409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.